<?xml version='1.0' encoding='UTF-8'?><rss xmlns:atom='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:thr='http://purl.org/syndication/thread/1.0' version='2.0'><channel><atom:id>tag:blogger.com,1999:blog-4834655537110960213</atom:id><lastBuildDate>Fri, 07 May 2010 16:00:16 +0000</lastBuildDate><title>Flomax Psoriasis</title><description>All the latest on Flomax Psoriasis</description><link>http://go-discover.com/Flomax_Psoriasis/</link><managingEditor>noreply@blogger.com (MarcoPolo)</managingEditor><generator>Blogger</generator><openSearch:totalResults>256</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-4890954322120002389</guid><pubDate>Fri, 07 May 2010 16:00:00 +0000</pubDate><atom:updated>2010-05-07T17:00:16.697+01:00</atom:updated><title>A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of Infection</title><description>&lt;b&gt;Condition&lt;/b&gt;:    HIV Infections&lt;br&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Ampligen&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified August 1991        &lt;a target="_blank" rel="nofollow" href='http://clinicaltrials.gov/ct2/show/NCT00001000       '&gt;go on..&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    Opioid-Related Disorders&lt;br&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: LAAM&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute on Drug Abuse (NIDA)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified March 1995        &lt;a target="_blank" rel="nofollow" href='http://clinicaltrials.gov/ct2/show/NCT00000300       '&gt;go on..&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    Cytomegalovirus Infections&lt;br&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: ganciclovir&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified November 2005        &lt;a target="_blank" rel="nofollow" href='http://clinicaltrials.gov/ct2/show/NCT00001100       '&gt;go on..&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;Conditions&lt;/b&gt;:    Anorexia;   Cachexia;   HIV Infections&lt;br&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Megestrol acetate&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bristol-Myers Squibb&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified October 2007        &lt;a target="_blank" rel="nofollow" href='http://clinicaltrials.gov/ct2/show/NCT00002300       '&gt;go on..&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    Cocaine-Related Disorders&lt;br&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Methadone&lt;br&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Institute on Drug Abuse (NIDA);   Columbia University&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified September 2008        &lt;a target="_blank" rel="nofollow" href='http://clinicaltrials.gov/ct2/show/NCT00000200       '&gt;go on..&lt;/a&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-4890954322120002389?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/05/study-of-atvogen-in-healthy-volunteers.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-4891221442501613985</guid><pubDate>Mon, 03 May 2010 04:01:00 +0000</pubDate><atom:updated>2010-05-03T05:01:12.367+01:00</atom:updated><title>The Effects of Illnesses on HIV Levels in the Body</title><description>&lt;a target="_blank" rel="nofollow" href="http://clinicaltrials.gov/ct2/show/NCT00000900       " &gt;The Effects of Illnesses on HIV Levels in the Body       &lt;/a&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    HIV Infections&lt;br&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified April 1999       &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.medicinenet.com/guide.asp?s=rss&amp;a=115792&amp;k=Skin_General " &gt;Is Drinking Wine a Key to Antiaging? &lt;/a&gt;&lt;br&gt;Title: Is Drinking Wine a Key to Antiaging?&lt;br&gt;Category: Health News&lt;br&gt;Created: 4/28/2010 9:36:00 AM&lt;br&gt;Last Editorial Review: 4/28/2010 9:36:34 AM &lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-4891221442501613985?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/05/effects-of-illnesses-on-hiv-levels-in.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-783558689895550973</guid><pubDate>Sat, 01 May 2010 22:00:00 +0000</pubDate><atom:updated>2010-05-01T23:00:42.550+01:00</atom:updated><title>Two Companies Begin Selling Generic Flomax - HealthCentral.com</title><description>Two drugmakers have started selling generic versions of the drug Flomax. Teva Pharmaceuticals and Mylan Inc. are the second and third companies to begin selling the generic version   &lt;a target="_blank" rel="nofollow" href='http://www.healthcentral.com/prostate/news-516768-98.html'&gt;Continue ..&lt;/a&gt;&lt;br&gt;&lt;br&gt;MILWAUKEE (AP) -- A German-based pharmaceutical company has agreed to pay $7.75 million to settle allegations that four of its subsidiaries committed price fraud, Wisconsin   &lt;a target="_blank" rel="nofollow" href='http://hosted.ap.org/dynamic/stories/W/WI_DRUGMAKER_LAWSUIT?SITE=NYPLA&amp;SECTION=MONEY&amp;TEMPLATE=DEFAULT&amp;CTIME=2010-04-20-14-41-11'&gt;Continue ..&lt;/a&gt;&lt;br&gt;&lt;br&gt;Two of the world's largest generic drugmakers said Wednesday they started selling their own versions of Flomax, a drug that treats enlarged prostate, after getting approval from   &lt;a target="_blank" rel="nofollow" href='http://www.businessweek.com/ap/financialnews/D9FC45BG1.htm'&gt;Continue ..&lt;/a&gt;&lt;br&gt;&lt;br&gt;(RTTNews) - Generic drugmaker Mylan Inc.(MYL: News ) Wednesday, announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug   &lt;a target="_blank" rel="nofollow" href='http://www.rttnews.com/Content/BreakingNews.aspx?Node=B1&amp;Id=1284530 &amp;Category=Breaking News'&gt;Continue ..&lt;/a&gt;&lt;br&gt;&lt;br&gt;A new book celebrating the 150th anniversary of Olympia's incorporation has been published by the city. “Olympia, Washington: A People’s History,” edited by historian Drew W   &lt;a target="_blank" rel="nofollow" href='http://www.thenewstribune.com/2010/04/30/1168711/aol-reportedly-selling-assets.html'&gt;Continue ..&lt;/a&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-783558689895550973?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/05/two-companies-begin-selling-generic.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-1294385145164976272</guid><pubDate>Fri, 30 Apr 2010 02:00:00 +0000</pubDate><atom:updated>2010-04-30T03:00:38.278+01:00</atom:updated><title>Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer</title><description>&lt;i&gt;&lt;b&gt;Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer       &lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;b&gt;Conditions&lt;/b&gt;:    Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer&lt;br&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: filgrastim;   Drug: carboplatin;   Drug: cyclophosphamide;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Sidney Kimmel Comprehensive Cancer Center&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified September 2001       &lt;br&gt;&lt;i&gt;Source: clinicaltrials.gov&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;i&gt;&lt;b&gt;A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients       &lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    HIV Infections&lt;br&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Indinavir sulfate;   Drug: Delavirdine mesylate;   Drug: Lamivudine;   Drug: Zidovudine&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Pharmacia and Upjohn&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified January 1999       &lt;br&gt;&lt;i&gt;Source: clinicaltrials.gov&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;i&gt;&lt;b&gt;A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.       &lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    Cytomegalovirus Infections&lt;br&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: ganciclovir&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified November 2005       &lt;br&gt;&lt;i&gt;Source: clinicaltrials.gov&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;i&gt;&lt;b&gt;A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma       &lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    Sarcoma&lt;br&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: doxorubicin;   Drug: ifosfamide;   Drug: mesna&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified April 2000       &lt;br&gt;&lt;i&gt;Source: clinicaltrials.gov&lt;/i&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-1294385145164976272?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/combination-chemotherapy-bone-marrow.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-3034119000105466638</guid><pubDate>Thu, 29 Apr 2010 02:00:00 +0000</pubDate><atom:updated>2010-04-29T03:00:50.031+01:00</atom:updated><title>A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma</title><description>&lt;i&gt;&lt;b&gt;A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma       &lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    Sarcoma&lt;br&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: doxorubicin;   Drug: ifosfamide;   Drug: mesna&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified April 2000       &lt;br&gt;&lt;i&gt;Source: clinicaltrials.gov&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;i&gt;&lt;b&gt;Psoriasis drugs put to the test 				&lt;/b&gt;&lt;/i&gt;&lt;br&gt;Clinical trials to test the effectiveness of two prescription drugs for the debilitating skin condition psoriasis have revealed significant differences that should help inform physicians treating patients with the condition. 				&lt;br&gt;&lt;i&gt;Source: www.sciencedaily.com&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;i&gt;&lt;b&gt;Two-pronged Attack Works Best For Psoriasis Treatment 				&lt;/b&gt;&lt;/i&gt;&lt;br&gt;Scientists find that two commonly used topical treatments work best together to treat chronic psoriasis, but are not a cure. 				&lt;br&gt;&lt;i&gt;Source: www.sciencedaily.com&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;i&gt;&lt;b&gt;New Skin-healing Chemicals 				&lt;/b&gt;&lt;/i&gt;&lt;br&gt;Researchers have made synthetic lipids called pseudoceramides that are involved in skin cell growth and could be used in treating skin diseases in which skin cells grow abnormally. Ceramides are lipids found in the outermost skin layer called the stratum corneum, which is made of dead skin cells and mainly serves as a physical barrier. Ceramides' main biological function is to control how skin cells grow and differentiate -- a process through which skin cells become specialized. 				&lt;br&gt;&lt;i&gt;Source: www.sciencedaily.com&lt;/i&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-3034119000105466638?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/randomized-study-of-effect-of-adjuvant.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-5083230016495381806</guid><pubDate>Fri, 23 Apr 2010 14:01:00 +0000</pubDate><atom:updated>2010-04-23T15:01:50.212+01:00</atom:updated><title>Drugmaker settles price-fraud lawsuit with Wis. - The Associated Press</title><description>&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.google.com%2Fhostednews%2Fap%2Farticle%2FALeqM5ikSGoRiMlXrRojco_h_w4YuG1l3AD9F6VAGO1&amp;amp;usg=AFQjCNGnV0pbHYyGNcVqX9NAqyZTMKD1hw"&gt;&lt;b&gt;Drugmaker settles price-fraud lawsuit with Wis.&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;The Associated Press&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;Boehringer Ingelheim makes products including &lt;b&gt;Flomax&lt;/b&gt;, which is used to treat urinary symptoms related to an enlarged prostate, and Spiriva, used to treat &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=d_ydAvWcbJ4X_hM"&gt;&lt;nobr&gt;&lt;b&gt;and more&amp;nbsp;&amp;raquo;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;a target="_blank" rel="nofollow" href='http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://www.google.com/hostednews/ap/article/ALeqM5ikSGoRiMlXrRojco_h_w4YuG1l3AD9F6VAGO1&amp;usg=AFQjCNGnV0pbHYyGNcVqX9NAqyZTMKD1hw'&gt;More Here......&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.businessweek.com%2Fnews%2F2010-04-20%2Fboehringer-ingelheim-2009-profit-rises-on-spiriva-flomax-sales.html&amp;amp;usg=AFQjCNEb1pCZyITlCxzBopLN-ByFhaFzBw"&gt;&lt;b&gt;Boehringer Ingelheim Sees 2010 Sales Flat on Patent Losses&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;BusinessWeek&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;Boehringer needs to plug the gap left this year when generic competitors take sales from its prostate drug &lt;b&gt;Flomax&lt;/b&gt; and Parkinson&amp;#39;s therapy Mirapex, &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=dhQ-mhWShN6VwDM"&gt;&lt;nobr&gt;&lt;b&gt;and more&amp;nbsp;&amp;raquo;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;a target="_blank" rel="nofollow" href='http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://www.businessweek.com/news/2010-04-20/boehringer-ingelheim-2009-profit-rises-on-spiriva-flomax-sales.html&amp;usg=AFQjCNEb1pCZyITlCxzBopLN-ByFhaFzBw'&gt;More Here......&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.i-newswire.com%2Fflomax-relief-offered-without-a%2F33172&amp;amp;usg=AFQjCNHK5xZEN9HXrr7cgz_pg1P4Rxkfvw"&gt;&lt;b&gt;&lt;b&gt;Flomax&lt;/b&gt; Relief offered without a Prescription at Chemist Direct&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;I-Newswire.com (press release)&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;(I-Newswire) April 23, 2010 - Formerly available only with a prescription from reputed doctor, &lt;b&gt;Flomax&lt;/b&gt; Relief MR is the most extensively preferred treatment &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=dB1AN-YvoKl2rnM"&gt;&lt;nobr&gt;&lt;b&gt;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;a target="_blank" rel="nofollow" href='http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://www.i-newswire.com/flomax-relief-offered-without-a/33172&amp;usg=AFQjCNHK5xZEN9HXrr7cgz_pg1P4Rxkfvw'&gt;More Here......&lt;/a&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-5083230016495381806?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/drugmaker-settles-price-fraud-lawsuit.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-6408109235446530450</guid><pubDate>Thu, 22 Apr 2010 18:02:00 +0000</pubDate><atom:updated>2010-04-22T19:02:03.657+01:00</atom:updated><title>Possible Key To Autoimmune Disease</title><description>&lt;a target="_blank" rel="nofollow" href="http://www.sciencedaily.com/releases/2007/09/070916143504.htm 				" &gt;Possible Key To Autoimmune Disease 				&lt;/a&gt;&lt;br&gt;A self DNA-peptide complex triggers an immune response like that caused by a virus or other invading microbe. Researchers believe this response is both a likely key driver of autoimmune disease and an integral part of an early warning system that flags tissue damage to launch a protective inflammatory response to injury. 				&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.sciencedaily.com/releases/2010/02/100224083054.htm 				" &gt;Reversing Remodeling in Chronic Inflammation 				&lt;/a&gt;&lt;br&gt;Scientists have discovered that remodeling of lymphatic vessels may be more persistent than blood vessel remodeling as a result of inflammation. 				&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.sciencedaily.com/releases/2007/10/071027100558.htm 				" &gt;Oil And Water Mix For Skin Care Treatment In Winter Season 				&lt;/a&gt;&lt;br&gt;As the weather turns colder, dry skin becomes a common problem for most people. Most lotions and creams contain one or both of the following agents - an oily agent and a watery agent. A little background on the make-up of skin creams would make selecting the right cream easier. 				&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.sciencedaily.com/releases/2008/10/081023144119.htm 				" &gt;Green Tea May Delay Onset Of Type 1 Diabetes 				&lt;/a&gt;&lt;br&gt;A powerful antioxidant in green tea may prevent or delay the onset of type 1 diabetes, Medical College of Georgia researchers say. Researchers were testing EGCG, green tea's predominant antioxidant, in a laboratory mouse with type 1 diabetes and primary Sjogren's syndrome, which damages moisture-producing glands, causing dry mouth and eyes. 				&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.sciencedaily.com/releases/2008/03/080324124350.htm 				" &gt;Patients With Psoriasis At Increased Risk For Developing Other Serious Medical Conditions 				&lt;/a&gt;&lt;br&gt;It has long been known that psoriasis, a chronic skin condition characterized by thick, red, scaly plaques that itch and bleed, can have a significant negative impact on a patient's overall quality of life. Now, dermatologists are finding that psoriasis, especially severe psoriasis, is linked with a number of serious medical conditions -- including cardiovascular disease, depression and cancer. 				&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-6408109235446530450?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/possible-key-to-autoimmune-disease.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-8125794098897928923</guid><pubDate>Wed, 21 Apr 2010 18:04:00 +0000</pubDate><atom:updated>2010-04-21T19:04:39.980+01:00</atom:updated><title>Resistant Ringworm Common in Urban Elementary Schools</title><description>&lt;a target="_blank" rel="nofollow" href="http://www.medicinenet.com/guide.asp?s=rss&amp;a=115515&amp;k=Skin_General " &gt;Resistant Ringworm Common in Urban Elementary Schools &lt;/a&gt;&lt;br&gt;Title: Resistant Ringworm Common in Urban Elementary Schools&lt;br&gt;Category: Health News&lt;br&gt;Created: 4/19/2010 10:10:00 AM&lt;br&gt;Last Editorial Review: 4/20/2010 &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://clinicaltrials.gov/ct2/show/NCT00002800       " &gt;Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome       &lt;/a&gt;&lt;br&gt;&lt;b&gt;Conditions&lt;/b&gt;:    Leukemia;   Myelodysplastic Syndromes;   Neutropenia&lt;br&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: filgrastim;   Biological: lintuzumab;   Drug: cytarabine;   Drug: etoposide;   Drug: idarubicin&lt;br&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Memorial Sloan-Kettering Cancer Center;   National Cancer Institute (NCI)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified December 2009       &lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-8125794098897928923?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/resistant-ringworm-common-in-urban.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-1758159854550279427</guid><pubDate>Sat, 17 Apr 2010 04:06:00 +0000</pubDate><atom:updated>2010-04-17T05:06:29.152+01:00</atom:updated><title>Happening Today - Norristown Times Herald</title><description>&lt;i&gt;&lt;b&gt;Happening Today - Norristown Times Herald&lt;/b&gt;&lt;/i&gt;&lt;br&gt;Bookmobiles of the Montgomery County Library District will be at Upper Frederick Township Building, Route 73, Obelisk, 10 a.m. to noon.; Ralph’s Corner, Routes 63 and 463  &lt;br&gt;&lt;i&gt;Source: www.timesherald.com&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;i&gt;&lt;b&gt;VITAMIN D - WebMD&lt;/b&gt;&lt;/i&gt;&lt;br&gt;Alfacalcidol: 1-alpha-hydroxycholecalciferol, 1 alpha (OH)D3. Calcifediol: 25-HCC, 25-hydroxycholecalciferol, 25-hydroxyvitamin D3, 25-OHCC, 25-OHD3. Calcipotriene: Calcipotriol  &lt;br&gt;&lt;i&gt;Source: www.webmd.com&lt;/i&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-1758159854550279427?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/happening-today-norristown-times-herald.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-4981976256881633258</guid><pubDate>Fri, 16 Apr 2010 04:06:00 +0000</pubDate><atom:updated>2010-04-16T05:06:49.076+01:00</atom:updated><title>MHRA clears switch of Flomax and Cyklo-F to OTC medicines - Pharma Times</title><description>&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://www.pharmatimes.com/UKNews/article.aspx?id=17650&amp;usg=AFQjCNENt3rorVIULqnYZyaiwSd0MEmEFQ" &gt;MHRA clears switch of Flomax and Cyklo-F to OTC medicines - Pharma Times&lt;/a&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.pharmatimes.com%2FUKNews%2Farticle.aspx%3Fid%3D17650&amp;amp;usg=AFQjCNENt3rorVIULqnYZyaiwSd0MEmEFQ"&gt;&lt;b&gt;MHRA clears switch of &lt;b&gt;Flomax&lt;/b&gt; and Cyklo-F to OTC medicines&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;Pharma Times&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;Boehringer Ingelheim&amp;#39;s prostate enlargement drug &lt;b&gt;Flomax&lt;/b&gt; Relief MR and Cyklo for heavy menstrual bleeding are now available through pharmacists following &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fdrugstorenews.com%2Fstory.aspx%3Fid%3D135153%26menuid%3D793&amp;amp;usg=AFQjCNF8w85IYMK5MgKgGXZUTS-KkGoBHg"&gt;New OTC category develops on heels of UK&amp;#39;s Cyklo-F approval&lt;/a&gt;&lt;font size="-1" color="#6f6f6f"&gt;&lt;nobr&gt;Drug Store News&lt;/nobr&gt;&lt;/font&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=dpnfvMQHp5aCtjMA4L4zO8x6Af8-M"&gt;&lt;nobr&gt;&lt;b&gt;all 3 news articles&amp;nbsp;&amp;raquo;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://www.beatweek.com/news/3966-jay-leno-makes-obligatory-ipad-joke/&amp;usg=AFQjCNHPOBMosshOy27caaL7aTqx0hMAyw" &gt;Jay Leno makes obligatory iPad joke - Beatweek Magazine&lt;/a&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.beatweek.com%2Fnews%2F3966-jay-leno-makes-obligatory-ipad-joke%2F&amp;amp;usg=AFQjCNHPOBMosshOy27caaL7aTqx0hMAyw"&gt;&lt;img src="http://nt0.ggpht.com/news/tbn/WPyFVWY5PoiFmM/6.jpg" alt="" border="1" width="80" height="80" /&gt;&lt;br&gt;&lt;font size="-2"&gt;Beatweek Magazine&lt;/font&gt;&lt;/a&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.beatweek.com%2Fnews%2F3966-jay-leno-makes-obligatory-ipad-joke%2F&amp;amp;usg=AFQjCNHPOBMosshOy27caaL7aTqx0hMAyw"&gt;&lt;b&gt;Jay Leno makes obligatory iPad joke&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;Beatweek Magazine&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;So what do you get, according to Leno, when you combine the iPad with the drug &lt;b&gt;Flomax&lt;/b&gt;? Complete with a fake iPad mockup with urine splashing on the iPad&amp;#39;s &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=d1DtsMT_h0ANXaM"&gt;&lt;nobr&gt;&lt;b&gt;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://www.reuters.com/article/idUSLDE62U0WO20100331&amp;usg=AFQjCNGmXBaWIBgi5OTryq8ZjqBZgW1ZHg" &gt;Glaxo two-in-one prostrate drug approved in Europe - Reuters&lt;/a&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.reuters.com%2Farticle%2FidUSLDE62U0WO20100331&amp;amp;usg=AFQjCNGmXBaWIBgi5OTryq8ZjqBZgW1ZHg"&gt;&lt;b&gt;Glaxo two-in-one prostrate drug approved in Europe&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;Reuters&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;It combines Glaxo&amp;#39;s established drug Avodart, or dutasteride with Astellas Pharma&amp;#39;s (4503.T) off patent product &lt;b&gt;Flomax&lt;/b&gt;, or tamsulosin. &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.google.com%2Fhostednews%2Fap%2Farticle%2FALeqM5hEGC19uu02L4tXsTy9TFLtM522swD9EPIQ3O0&amp;amp;usg=AFQjCNGMrUplhQn0ndlCmu_UnZYBXxrrqA"&gt;GSK receives EU approval for prostate drug&lt;/a&gt;&lt;font size="-1" color="#6f6f6f"&gt;&lt;nobr&gt;The Associated Press&lt;/nobr&gt;&lt;/font&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.docguide.com%2Fnews%2Fcontent.nsf%2Fnews%2F852576140048867C852576F7005A5370&amp;amp;usg=AFQjCNEzfsFZU4_BV9J85otq4nvukW4nrA"&gt;Dutasteride/Tamsulosin Combination for BPH Approved in Europe&lt;/a&gt;&lt;font size="-1" color="#6f6f6f"&gt;&lt;nobr&gt;DG News&lt;/nobr&gt;&lt;/font&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.tradingmarkets.com%2Fnews%2Fstock-alert%2Fgsk_glaxosmithkline-eu-approval-bodes-well-for-future-blockbuster-884061.html&amp;amp;usg=AFQjCNFJXambWscSztaChdwAPXaesF7uYQ"&gt;GlaxoSmithKline: EU approval bodes well for future blockbuster&lt;/a&gt;&lt;font size="-1" color="#6f6f6f"&gt;&lt;nobr&gt;Trading Markets (press release)&lt;/nobr&gt;&lt;/font&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.genengnews.com%2Fnews%2Fbnitem.aspx%3Fname%3D79139822&amp;amp;usg=AFQjCNG3fJYxdon5Iic8kGgQcTHAvk1DrQ"&gt;&lt;nobr&gt;Genetic Engineering News (press release)&lt;/nobr&gt;&lt;/a&gt;&amp;nbsp;-&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fenglish.capital.gr%2Fnews.asp%3Fid%3D936723&amp;amp;usg=AFQjCNFu9k05LlJtEV3OjgmtiTogXk8IJg"&gt;&lt;nobr&gt;Capital.gr (press release)&lt;/nobr&gt;&lt;/a&gt;&amp;nbsp;-&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.onlineprnews.com%2Fnews%2F28565-1270038779-benign-prostatic-hyperplasia-drug-pipeline-analysis-and-market-forecasts-to-2016.html&amp;amp;usg=AFQjCNGH76D3_4yc15n3rvT7XVnp19JsPA"&gt;&lt;nobr&gt;Online PR News (press release)&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=dC5afQj6b2ONyLMBRRlER2fU_Iu6M"&gt;&lt;nobr&gt;&lt;b&gt;all 132 news articles&amp;nbsp;&amp;raquo;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://www.dailymail.co.uk/health/article-1265526/Pharmacists-selling-drugs-counter-patients-havent-consulted-doctor-chemist-putting-life-risk.html&amp;usg=AFQjCNFJgNNVdi9nmyMkBCkvQRN4nKuCbA" &gt;Pharmacists are selling more drugs over the counter to patients who haven't ... - Daily Mail&lt;/a&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.dailymail.co.uk%2Fhealth%2Farticle-1265526%2FPharmacists-selling-drugs-counter-patients-havent-consulted-doctor-chemist-putting-life-risk.html&amp;amp;usg=AFQjCNFJgNNVdi9nmyMkBCkvQRN4nKuCbA"&gt;&lt;img src="http://nt2.ggpht.com/news/tbn/NoPocrC_exAV3M/6.jpg" alt="" border="1" width="80" height="80" /&gt;&lt;br&gt;&lt;font size="-2"&gt;Daily Mail&lt;/font&gt;&lt;/a&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.dailymail.co.uk%2Fhealth%2Farticle-1265526%2FPharmacists-selling-drugs-counter-patients-havent-consulted-doctor-chemist-putting-life-risk.html&amp;amp;usg=AFQjCNFJgNNVdi9nmyMkBCkvQRN4nKuCbA"&gt;&lt;b&gt;Pharmacists are selling more drugs over the counter to patients who haven&amp;#39;t &lt;b&gt;...&lt;/b&gt;&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;Daily Mail&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;Tamsulosin, the active ingredient in &lt;b&gt;Flomax&lt;/b&gt; MR, has been used successfully for many years as a first-line treatment to alleviate the symptoms of a very &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=dNkg-ScW_2ZMUrM"&gt;&lt;nobr&gt;&lt;b&gt;and more&amp;nbsp;&amp;raquo;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-4981976256881633258?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/mhra-clears-switch-of-flomax-and-cyklo.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-4826937725261280435</guid><pubDate>Thu, 15 Apr 2010 06:03:00 +0000</pubDate><atom:updated>2010-04-15T07:03:24.768+01:00</atom:updated><title>Mylan begins shipping generic version of Glaxo - Gaea Times (blog)</title><description>&lt;a target="_blank" rel="nofollow" href="http://blog.taragana.com/business/2010/04/12/mylan-begins-shipping-generic-version-of-glaxo-antidepressant-wellbutrin-sr-after-fda-approval-49572/" &gt;Mylan begins shipping generic version of Glaxo   - Gaea Times (blog)&lt;/a&gt;&lt;br&gt;PITTSBURGH — Mylan Inc. said Monday it started shipping a generic version of the antidepressant Wellbutrin SR after getting approval from the Food and Drug Administration. The  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://business.rediff.com/slide-show/2010/apr/09/slide-show-1-the-us-healthcare-opportunity-for-Indian-firms.htm" &gt;The US healthcare opportunity for India - Rediff&lt;/a&gt;&lt;br&gt;H ealthcare stocks seem to be on a bit of a roll recently. The BSE Healthcare index delivered 12 per cent compared to Sensex's 8 per cent gain since January this year. A large part  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.omaha.com/article/20100410/SPORTS/704109734" &gt;Dickson's Week in Review - Omaha World-Herald&lt;/a&gt;&lt;br&gt;Omaha native Brad Dickson reviews this week in sports. Dickson is a former writer for “The Tonight Show with Jay Leno.” Tiger Woods is doing all he can to repair his image. His  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.businesswire.com/news/home/20100414005887/en/Research-Markets-Benign-Prostatic-Hyperplasia---Drug" &gt;Research and Markets: Benign Prostatic Hyperplasia   - Businesswire.com&lt;/a&gt;&lt;br&gt;“Benign Prostatic Hyperplasia - Drug Pipeline Analysis and Market Forecasts to 2016” Benign Prostatic Hyperplasia - Drug Pipeline Analysis and Market Forecasts to 2016 is an  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.sanfranciscosentinel.com/?p=68259" &gt;No Comments » - SanFranciscoSentinel.com&lt;/a&gt;&lt;br&gt;Jon Stewart: Bombs Away, The Big Bang Treaty: President Obama signed an arms reduction treaty with Russia. Sure, it’s easy to sign a treaty with a communist country you’ve  &lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-4826937725261280435?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/mylan-begins-shipping-generic-version.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-1810377460769429072</guid><pubDate>Mon, 12 Apr 2010 12:04:00 +0000</pubDate><atom:updated>2010-04-12T13:04:18.258+01:00</atom:updated><title>NexMed Announces Expansion of Its Bio-Quant Subsidiary Facilities - MarketWatch (press release)</title><description>&lt;i&gt;&lt;b&gt;NexMed Announces Expansion of Its Bio-Quant Subsidiary Facilities - MarketWatch (press release)&lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.marketwatch.com%2Fstory%2Fnexmed-announces-expansion-of-its-bio-quant-subsidiary-facilities-2010-04-09%3Freflink%3DMW_news_stmp&amp;amp;usg=AFQjCNFUCwHBGzEyrwtSoIzB2lcZy2v6dg"&gt;&lt;b&gt;NexMed Announces Expansion of Its Bio-Quant Subsidiary Facilities&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;MarketWatch (press release)&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;At the same time, NexMed is actively pursuing partnering opportunities for its NexACT-based treatments for onychomycosis, &lt;b&gt;psoriasis&lt;/b&gt;, sexual dysfunction and &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=dUDoJ4Ess6iv4XM"&gt;&lt;nobr&gt;&lt;b&gt;and more&amp;nbsp;&amp;raquo;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;i&gt;Source: news.google.com&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;i&gt;&lt;b&gt;Indoor tanners to pay for health care reform - SDNN&lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.sdnn.com%2Fsandiego%2F2010-04-09%2Fpolitics-city-county-government%2Fstate-health%2Findoor-tanners-to-pay-for-health-care-reform&amp;amp;usg=AFQjCNFNXdqIOe5KLg_0Um3BYFVWaHCLnQ"&gt;&lt;b&gt;Indoor tanners to pay for health care reform&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;SDNN&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;Kearny Mesa resident Tamara Golaski tans about five times per week to manage her &lt;b&gt;psoriasis&lt;/b&gt;. Because she hasn&amp;#39;t been earning enough money working for a &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=dvqayVPp-Ccj_xM"&gt;&lt;nobr&gt;&lt;b&gt;and more&amp;nbsp;&amp;raquo;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;i&gt;Source: news.google.com&lt;/i&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-1810377460769429072?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/nexmed-announces-expansion-of-its-bio.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-4039821181327020574</guid><pubDate>Sat, 10 Apr 2010 14:04:00 +0000</pubDate><atom:updated>2010-04-10T15:04:17.895+01:00</atom:updated><title>Integrated network analysis of transcriptomic and proteomic data in psoriasis - 7thSpace Interactive (press release)</title><description>&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://7thspace.com/headlines/340830/integrated_network_analysis_of_transcriptomic_and_proteomic_data_in_psoriasis.html&amp;usg=AFQjCNG7JfByZrJNL9sVAKZTIViJIPDH5w" &gt;Integrated network analysis of transcriptomic and proteomic data in psoriasis - 7thSpace Interactive (press release)&lt;/a&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2F7thspace.com%2Fheadlines%2F340830%2Fintegrated_network_analysis_of_transcriptomic_and_proteomic_data_in_psoriasis.html&amp;amp;usg=AFQjCNG7JfByZrJNL9sVAKZTIViJIPDH5w"&gt;&lt;b&gt;Integrated network analysis of transcriptomic and proteomic data in &lt;b&gt;psoriasis&lt;/b&gt;&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;7thSpace Interactive (press release)&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;Psoriasis&lt;/b&gt; is complex inflammatory skin pathology of autoimmune origin. Its pathogenesis perturbs several cell types and is characterized by poorly &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=d4AR5l1k1RsGG5M"&gt;&lt;nobr&gt;&lt;b&gt;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://www.officialwire.com/main.php?action=posted_news&amp;rid=126433&amp;usg=AFQjCNFJOLdUVy8mO0DOApHWVSvybV16Ew" &gt;Medical Laser Systems - A Global Update Of Market Trends &amp; Opportunities - New ... - OfficialWire (press release)&lt;/a&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.officialwire.com%2Fmain.php%3Faction%3Dposted_news%26rid%3D126433&amp;amp;usg=AFQjCNFJOLdUVy8mO0DOApHWVSvybV16Ew"&gt;&lt;b&gt;Medical Laser Systems - A Global Update Of Market Trends &amp;amp; Opportunities - New &lt;b&gt;...&lt;/b&gt;&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;OfficialWire (press release)&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;...&lt;/b&gt; promising emergent medical laser applications and technologies receiving much attention include treatment of skin disorders such as &lt;b&gt;psoriasis&lt;/b&gt; and acne. &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=d1oiBoRDQ0yGUWM"&gt;&lt;nobr&gt;&lt;b&gt;and more&amp;nbsp;&amp;raquo;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://www.thedenverchannel.com/health/23107663/detail.html&amp;usg=AFQjCNHw2yp2toVpEwQpIhDaPVTDzT8q_Q" &gt;Doctors Find 'Shadow Diseases' Linked To Primary Disease - KMGH Denver&lt;/a&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.thedenverchannel.com%2Fhealth%2F23107663%2Fdetail.html&amp;amp;usg=AFQjCNHw2yp2toVpEwQpIhDaPVTDzT8q_Q"&gt;&lt;b&gt;Doctors Find &amp;#39;Shadow Diseases&amp;#39; Linked To Primary Disease&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;KMGH Denver&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;Sam Jonas has &lt;b&gt;psoriasis&lt;/b&gt;, a skin disease that leaves scaly patches on his body. In 2006, Sam also had a heart attack. Until now, he didn&amp;#39;t know the two &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=dXuPVSUUQLpjgoM"&gt;&lt;nobr&gt;&lt;b&gt;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://events.wcnc.com/charlotte/events/walk-psoriasis-and-psoriatic-arthritis-/E0-001-029726920-8?ref=belowidget&amp;usg=AFQjCNHtssSgTaud6SbmVwIWAGz-JKJUrQ" &gt;Walk for Psoriasis and Psoriatic Arthritis - WCNC (subscription)&lt;/a&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fevents.wcnc.com%2Fcharlotte%2Fevents%2Fwalk-psoriasis-and-psoriatic-arthritis-%2FE0-001-029726920-8%3Fref%3Dbelowidget&amp;amp;usg=AFQjCNHtssSgTaud6SbmVwIWAGz-JKJUrQ"&gt;&lt;b&gt;Walk for &lt;b&gt;Psoriasis&lt;/b&gt; and &lt;b&gt;Psoriatic&lt;/b&gt; Arthritis&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;WCNC (subscription)&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;You may have &lt;b&gt;psoriasis&lt;/b&gt;. Although you may only have a mild form, you may be one flare away from being disabled.** I am organizing a Walk for &lt;b&gt;Psoriasis&lt;/b&gt; and &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=dWhKt3F35A0ep8M"&gt;&lt;nobr&gt;&lt;b&gt;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-4039821181327020574?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/integrated-network-analysis-of.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-6914026257266364192</guid><pubDate>Fri, 09 Apr 2010 15:59:00 +0000</pubDate><atom:updated>2010-04-09T16:59:59.782+01:00</atom:updated><title>after stopping flomax does hair come back ? - HealthCentral.com</title><description>If you are a breast cancer survivor, check the name of the drug again. Flomax is mainly used for prostate issues. If it is used for breast cancer, I am not aware of it. Since we   &lt;a target="_blank" rel="nofollow" href='http://www.healthcentral.com/breast-cancer/c/question/919583/108589/'&gt;More Here  &lt;/a&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-6914026257266364192?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/after-stopping-flomax-does-hair-come.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-8820160595532716713</guid><pubDate>Tue, 06 Apr 2010 22:00:00 +0000</pubDate><atom:updated>2010-04-06T23:00:07.178+01:00</atom:updated><title>UPDATE 1-Glaxo two-in-one prostrate drug approved in - Interactive Investor</title><description>&lt;a target="_blank" rel="nofollow" href="http://www.iii.co.uk/news/?type=afxnews&amp;articleid=7820098&amp;subject=companies&amp;action=article" &gt;UPDATE 1-Glaxo two-in-one prostrate drug approved in   - Interactive Investor&lt;/a&gt;&lt;br&gt;LONDON, March 31 (Reuters) - Duodart, a two-in-one prostrate drug from GlaxoSmithKline, has been approved in Europe, the British drugmaker said on Wednesday. The backing -- from  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.healthcentral.com/prostate/c/question/648542/108175/" &gt;Avodart vs. TURP for BPH Symptoms when med mgt   - HealthCentral.com&lt;/a&gt;&lt;br&gt;I am 67 yrs old &amp; have had bothersome urine frequency &amp; nocturia BPH symptoms for over 12 years. I have been treated with Flomax &amp; tried the microwave procedures to no avail. My  &lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-8820160595532716713?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/update-1-glaxo-two-in-one-prostrate.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-1976954550278072919</guid><pubDate>Mon, 05 Apr 2010 22:00:00 +0000</pubDate><atom:updated>2010-04-05T23:00:19.673+01:00</atom:updated><title>Alendronate and/or Parathyroid Hormone for Osteoporosis</title><description>&lt;i&gt;&lt;b&gt;Alendronate and/or Parathyroid Hormone for Osteoporosis       &lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    Osteoporosis&lt;br&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Human parathyroid hormone [hPTH-(1-34)];   Drug: alendronate&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified November 2008       &lt;br&gt;&lt;i&gt;Source: clinicaltrials.gov&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;i&gt;&lt;b&gt;A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP       &lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    HIV Infections&lt;br&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Zidovudine&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified September 2002       &lt;br&gt;&lt;i&gt;Source: clinicaltrials.gov&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;i&gt;&lt;b&gt;Recently Discovered Cell Is Unexpected Player In Psoriasis 				&lt;/b&gt;&lt;/i&gt;&lt;br&gt;When the FDA assesses a drug, it looks closely at its safety and its effectiveness, but it doesn't require a precise understanding of how the drug works. A new study shows that a strikingly successful psoriasis drug, etanercept, may not act on the immune cells that scientists had originally believed. In fact, their findings indicate that the disease itself may be partially driven by these recently discovered cells. 				&lt;br&gt;&lt;i&gt;Source: www.sciencedaily.com&lt;/i&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-1976954550278072919?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/alendronate-andor-parathyroid-hormone.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-166952941276846346</guid><pubDate>Sun, 04 Apr 2010 00:00:00 +0000</pubDate><atom:updated>2010-04-04T01:00:39.501+01:00</atom:updated><title>Foot health: Beauty treatment with fish launched - Zee News</title><description>Dubai: If your feet are unsightly and the chemicals aren't having their way, here is an opportunity to clean in a 'fishy' way. FISHO, a beauty treatment that uses toothless fish to   &lt;a target="_blank" rel="nofollow" href='http://www.zeenews.com/news616268.html'&gt;Continue ..&lt;/a&gt;&lt;br&gt;&lt;br&gt;Have you checked with your doctor in medical scrubs whether your child is getting enough vitamin D needed for his or her growth? According to CDC, only 5% to 13% of breastfed   &lt;a target="_blank" rel="nofollow" href='http://www.owensoundsuntimes.com/Community/NewsDisplay.aspx?c=43821'&gt;Continue ..&lt;/a&gt;&lt;br&gt;&lt;br&gt;Tanning salons and customers will face increased regulation later this year. The new health care reform law includes a 10-percent tax on indoor tanning beds. The tax will take   &lt;a target="_blank" rel="nofollow" href='http://www.dailyemerald.com/news/fighting-tanning-with-taxes-1.1293225'&gt;Continue ..&lt;/a&gt;&lt;br&gt;&lt;br&gt;In the last 15 years, Kim Arnold said she has raised prices at her Tropical Tann stores no more than 3 percent. Come July, however, she and tanning salon owners across the country   &lt;a target="_blank" rel="nofollow" href='http://www.poststar.com/business/local/article_1d68f8c6-3f6d-11df-a959-001cc4c002e0.html'&gt;Continue ..&lt;/a&gt;&lt;br&gt;&lt;br&gt;Q: Some time ago, I discovered the benefits of eating a banana when I was experiencing a reflux problem. A year or so ago, I decided that a proactive approach would be better. I   &lt;a target="_blank" rel="nofollow" href='http://www.reformer.com/ci_14812588?source=most_viewed'&gt;Continue ..&lt;/a&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-166952941276846346?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/foot-health-beauty-treatment-with-fish.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-3079744603050740858</guid><pubDate>Fri, 02 Apr 2010 04:01:00 +0000</pubDate><atom:updated>2010-04-02T05:01:09.596+01:00</atom:updated><title>LeAnn Rimes raises psoriasis awareness - UPI.com</title><description>&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.upi.com%2FHealth_News%2F2010%2F03%2F31%2FLeAnn-Rimes-raises-psoriasis-awareness%2FUPI-19361270010321%2F&amp;amp;usg=AFQjCNGvywVV0kGj4N3-2sXoB0Ipxp4PeA"&gt;&lt;img src="http://nt3.ggpht.com/news/tbn/bxedBj8JA-3OdM/6.jpg" alt="" border="1" width="80" height="80" /&gt;&lt;br&gt;&lt;font size="-2"&gt;UPI.com&lt;/font&gt;&lt;/a&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.upi.com%2FHealth_News%2F2010%2F03%2F31%2FLeAnn-Rimes-raises-psoriasis-awareness%2FUPI-19361270010321%2F&amp;amp;usg=AFQjCNGvywVV0kGj4N3-2sXoB0Ipxp4PeA"&gt;&lt;b&gt;LeAnn Rimes raises &lt;b&gt;psoriasis&lt;/b&gt; awareness&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;UPI.com&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;SCHAUMBURG, Ill., March 31 (UPI) -- Recording artist LeAnn Rimes, who has been a &lt;b&gt;psoriasis&lt;/b&gt; patient since age 2, is heading a US campaign to raise awareness &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=d7_ElqejaOI4ajM"&gt;&lt;nobr&gt;&lt;b&gt;and more&amp;nbsp;&amp;raquo;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;a target="_blank" rel="nofollow" href='http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://www.upi.com/Health_News/2010/03/31/LeAnn-Rimes-raises-psoriasis-awareness/UPI-19361270010321/&amp;usg=AFQjCNGvywVV0kGj4N3-2sXoB0Ipxp4PeA'&gt;Read More....&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2F7thspace.com%2Fheadlines%2F340208%2Fdiffering_effect_of_systemic_anti_psoriasis_therapies_on_platelet_physiology___a_case_report_and_review_of_literature.html&amp;amp;usg=AFQjCNF5rZy5p6IdOofFOSTkI5Rl9pHnRQ"&gt;&lt;b&gt;Differing effect of systemic anti &lt;b&gt;psoriasis&lt;/b&gt; therapies on platelet physiology &lt;b&gt;...&lt;/b&gt;&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;7thSpace Interactive (press release)&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;Psoriasis&lt;/b&gt; is a common, chronic relapsing inflammatory skin disease. Lately, there is increasing evidence that &lt;b&gt;psoriasis&lt;/b&gt; is more than &amp;quot;skin deep&amp;quot;. &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=d_Nn7PpQ3NP2nrM"&gt;&lt;nobr&gt;&lt;b&gt;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;a target="_blank" rel="nofollow" href='http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://7thspace.com/headlines/340208/differing_effect_of_systemic_anti_psoriasis_therapies_on_platelet_physiology___a_case_report_and_review_of_literature.html&amp;usg=AFQjCNF5rZy5p6IdOofFOSTkI5Rl9pHnRQ'&gt;Read More....&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.emaxhealth.com%2F1275%2F66%2F36222%2Ffit-your-skin-program-psoriasis-patients.html&amp;amp;usg=AFQjCNH6-ABpcSMHiA0OxIUx0iY9MojbgQ"&gt;&lt;b&gt;Fit in Your Skin Program for &lt;b&gt;Psoriasis&lt;/b&gt; Patients&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;eMaxHealth&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;If you are among the 7.5 million Americans who suffers with &lt;b&gt;psoriasis&lt;/b&gt;, feeling good about your skin and yourself can be a challenge. &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=d51YiUZbU9qml-M"&gt;&lt;nobr&gt;&lt;b&gt;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;a target="_blank" rel="nofollow" href='http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://www.emaxhealth.com/1275/66/36222/fit-your-skin-program-psoriasis-patients.html&amp;usg=AFQjCNH6-ABpcSMHiA0OxIUx0iY9MojbgQ'&gt;Read More....&lt;/a&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-3079744603050740858?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/04/leann-rimes-raises-psoriasis-awareness.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-2552200133378670003</guid><pubDate>Thu, 25 Mar 2010 22:08:00 +0000</pubDate><atom:updated>2010-03-25T22:08:19.084Z</atom:updated><title>Flomax Oral : Uses, Side Effects, Interactions</title><description>&lt;a target="_blank" rel="nofollow" href="http://www.webmd.com/drugs/drug-4154-Flomax Oral.aspx?drugid=4154&amp;drugname=Flomax Oral" &gt;Flomax Oral : Uses, Side Effects, Interactions  &lt;/a&gt;&lt;br&gt;Find patient medical information for Flomax Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.drugs-med.com/pharmacy/flomax" &gt;Cheap Flomax online. Buy cheap Tamsulosin 0.2 mg  &lt;/a&gt;&lt;br&gt;Category Men's Health offers wide variety of branded name drugs and cheap generic medicines.&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.drugs.com/pdr/flomax.html" &gt;Flomax patient advice including side effects&lt;/a&gt;&lt;br&gt;Flomax information from Drugs.com. Flomax is used to treat the symptoms of an enlarged prostate—a condition technically known as benign prostatic hyperplasia or BPH. The  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.4flomax.com/help/side-effects.jsp" &gt;Side Effects | FLOMAX&lt;/a&gt;&lt;br&gt;Information on the known side effects of FLOMAX. FLOMAX is a prescription medication for BPH.&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.v-med-online.com/product/flomax/" &gt;Cheap Generic Flomax. Order Cheap Flomax online.&lt;/a&gt;&lt;br&gt;V-Med-Online.Com offers generic Flomax. Cheap Tamsulosin online.&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://prostate.emedtv.com/flomax/flomax-dosage.html" &gt;Flomax Dosage&lt;/a&gt;&lt;br&gt;This eMedTV segment explains that the starting Flomax dosage to treat an enlarged prostate is 0.4 mg once daily. This page also explains that if your symptoms do not improve  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.4flomax.com/help/take.jsp" &gt;FLOMAX Medication| FLOMAX&lt;/a&gt;&lt;br&gt;How to take FLOMAX. Includes recommended dosage amounts and more.&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-2552200133378670003?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/03/flomax-oral-uses-side-effects.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-7343259379837706431</guid><pubDate>Mon, 22 Mar 2010 10:07:00 +0000</pubDate><atom:updated>2010-03-22T10:07:24.299Z</atom:updated><title>Indian stock market and companies daily report (March 03, 2010, Wednesday) - Stock Markets Review</title><description>&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://www.stockmarketsreview.com/reports/indian_stock_market_and_companies_daily_report_20100303_3243/&amp;usg=AFQjCNF5dhoYVV7GcBLWk1HfJek9JYfkCA" &gt;Indian stock market and companies daily report (March 03, 2010, Wednesday) - Stock Markets Review&lt;/a&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.stockmarketsreview.com%2Freports%2Findian_stock_market_and_companies_daily_report_20100303_3243%2F&amp;amp;usg=AFQjCNF5dhoYVV7GcBLWk1HfJek9JYfkCA"&gt;&lt;b&gt;Indian stock market and companies daily report (March 03, 2010, Wednesday)&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;Stock Markets Review&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;The US FDA has rejected Ranbaxy&amp;#39;s ANDA to sell the generic version of &lt;b&gt;Flomax&lt;/b&gt;, which is use to treat enlarged prostate glands. The regulator announced that &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=dNkSFnoQdrHObNM"&gt;&lt;nobr&gt;&lt;b&gt;and more&amp;nbsp;&amp;raquo;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://www.reuters.com/article/idUSTKX00670120100312&amp;usg=AFQjCNGORdo1MkKa-AIG0-QgjGB_uxtpQw" &gt;Daiichi Sankyo sees US lifting Ranbaxy bans by 2012 - Reuters&lt;/a&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.indiatalkies.com%2F2010%2F03%2Fdaiichi-eyes-ranbaxy-expanding-africa-latin-america.html&amp;amp;usg=AFQjCNGAjcV5teZYa7ZhK34Cu2xVkiKPVg"&gt;&lt;img src="http://nt3.ggpht.com/news/tbn/m06abQR0SBtNzM/6.jpg" alt="" border="1" width="80" height="80" /&gt;&lt;br&gt;&lt;font size="-2"&gt;India Talkies&lt;/font&gt;&lt;/a&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.reuters.com%2Farticle%2FidUSTKX00670120100312&amp;amp;usg=AFQjCNGORdo1MkKa-AIG0-QgjGB_uxtpQw"&gt;&lt;b&gt;Daiichi Sankyo sees US lifting Ranbaxy bans by 2012&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;Reuters&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;Ranbaxy was previously expected to be one of the first few generic drug makers to launch a copy version of &lt;b&gt;Flomax&lt;/b&gt;, which could have made a major earnings &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.fiercepharma.com%2Fstory%2Fdaiichi-aims-double-profits-2013%2F2010-03-12&amp;amp;usg=AFQjCNHIYTecHAkBDT4iE4hQhkgoaSU5AQ"&gt;Daiichi aims to double profits by 2013&lt;/a&gt;&lt;font size="-1" color="#6f6f6f"&gt;&lt;nobr&gt;FiercePharma&lt;/nobr&gt;&lt;/font&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.bloombergutv.com%2Fstock-market%2Fstocks%2Fcommentary%2F380461%2Franbaxy-rebounds-on-robust-outlook.html&amp;amp;usg=AFQjCNEoo2pNyTK9LEQ_SnHUafuQFt5ItQ"&gt;Ranbaxy rebounds on robust outlook&lt;/a&gt;&lt;font size="-1" color="#6f6f6f"&gt;&lt;nobr&gt;BloombergUTV&lt;/nobr&gt;&lt;/font&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=dNEQ4exwZBiQWgMdsoKEEdLvNWHxM"&gt;&lt;nobr&gt;&lt;b&gt;all 67 news articles&amp;nbsp;&amp;raquo;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://www.reuters.com/article/idUSLDE62L0LU20100322&amp;usg=AFQjCNG-6_AdwZWYuhljZ2nNhHsqf2ZWow" &gt;Swiss back two-in-one Glaxo prostate drug Duodart - Reuters&lt;/a&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.reuters.com%2Farticle%2FidUSLDE62L0LU20100322&amp;amp;usg=AFQjCNG-6_AdwZWYuhljZ2nNhHsqf2ZWow"&gt;&lt;b&gt;Swiss back two-in-one Glaxo prostate drug Duodart&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;Reuters&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;It combines Glaxo&amp;#39;s established drug Avodart, or dutasteride, with Astellas Pharma&amp;#39;s (4503.T) off-patent product &lt;b&gt;Flomax&lt;/b&gt;, or tamsulosin. &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=d9SKMFMuDgMIy9M"&gt;&lt;nobr&gt;&lt;b&gt;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://online.wsj.com/article/BT-CO-20100225-711408.html?mod=WSJ_latestheadlines&amp;usg=AFQjCNEZgiafysTIUHdjbekY3ZNysfEggg" &gt;Ranbaxy Swings To Fourth Quarter Net Profit; Generic Sales Help - Wall Street Journal&lt;/a&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fonline.wsj.com%2Farticle%2FBT-CO-20100225-711408.html%3Fmod%3DWSJ_latestheadlines&amp;amp;usg=AFQjCNEZgiafysTIUHdjbekY3ZNysfEggg"&gt;&lt;b&gt;Ranbaxy Swings To Fourth Quarter Net Profit; Generic Sales Help&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;Wall Street Journal&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;Ranbaxy has the &amp;quot;first-to-file&amp;quot; status on &lt;b&gt;Flomax&lt;/b&gt;, the patent for which belongs to Japan&amp;#39;s Astellas Pharma Inc. Germany&amp;#39;s Boehringer Ingelheim GmbH markets &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=d3m-o9pclO7XaiM"&gt;&lt;nobr&gt;&lt;b&gt;and more&amp;nbsp;&amp;raquo;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http://online.wsj.com/article/SB10001424052748703862704575098820612090224.html?mod=WSJ_latestheadlines&amp;usg=AFQjCNH5hDDFnbpASxwbbyI3V3shMlv5CA" &gt;Ranbaxy Fails to Launch Generic Flomax - Wall Street Journal&lt;/a&gt;&lt;br&gt;&lt;table border="0" cellpadding="2" cellspacing="7" style="vertical-align:top;"&gt;&lt;tr&gt;&lt;td width="80" align="center" valign="top"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fbusiness.rediff.com%2Freport%2F2010%2Fmar%2F04%2Franbaxy-faces-more-trouble-in-us.htm&amp;amp;usg=AFQjCNGw6tC-b3z9w2iNaBBLLbPYUbwsyQ"&gt;&lt;img src="http://nt0.ggpht.com/news/tbn/VKwbzQmcDgxIcM/6.jpg" alt="" border="1" width="80" height="80" /&gt;&lt;br&gt;&lt;font size="-2"&gt;Rediff&lt;/font&gt;&lt;/a&gt;&lt;/font&gt;&lt;/td&gt;&lt;td valign="top" class="j"&gt;&lt;font style="font-size:85%;font-family:arial,sans-serif"&gt;&lt;br&gt;&lt;div style="padding-top:0.8em;"&gt;&lt;img alt="" height="1" width="1" /&gt;&lt;/div&gt;&lt;div class="lh"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fonline.wsj.com%2Farticle%2FSB10001424052748703862704575098820612090224.html%3Fmod%3DWSJ_latestheadlines&amp;amp;usg=AFQjCNH5hDDFnbpASxwbbyI3V3shMlv5CA"&gt;&lt;b&gt;Ranbaxy Fails to Launch Generic &lt;b&gt;Flomax&lt;/b&gt;&lt;/b&gt;&lt;/a&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;b&gt;&lt;font color="#6f6f6f"&gt;Wall Street Journal&lt;/font&gt;&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;had the &amp;quot;first-to-file&amp;quot; status on the generic version of &lt;b&gt;Flomax&lt;/b&gt;. Japan&amp;#39;s Astellas Pharma Inc. holds the patent on the urinary-disorder drug, while Germany&amp;#39;s &lt;b&gt;...&lt;/b&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.google.com%2Fhostednews%2Fap%2Farticle%2FALeqM5i-OgzVJqoE7jEjzW1uZZWKi2dWIwD9E6N9FO1&amp;amp;usg=AFQjCNGZJwFTsGOEs99-sIpLyvskyxxIYw"&gt;FDA grants final approval for generic &lt;b&gt;Flomax&lt;/b&gt;&lt;/a&gt;&lt;font size="-1" color="#6f6f6f"&gt;&lt;nobr&gt;The Associated Press&lt;/nobr&gt;&lt;/font&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.bloomberg.com%2Fapps%2Fnews%3Fpid%3D20601091%26sid%3Dai44eSty714Y&amp;amp;usg=AFQjCNEfOVuIYSXEKRhPwRTyPIf0fuTsVw"&gt;Daiichi Sankyo Says FDA Rejected Ranbaxy&amp;#39;s Generic &lt;b&gt;Flomax&lt;/b&gt;&lt;/a&gt;&lt;font size="-1" color="#6f6f6f"&gt;&lt;nobr&gt;Bloomberg&lt;/nobr&gt;&lt;/font&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.businessweek.com%2Flifestyle%2Fcontent%2Fhealthday%2F636606.html&amp;amp;usg=AFQjCNHKoDODCQSvRgRpTivwapwKhGEEYA"&gt;Generic &lt;b&gt;Flomax&lt;/b&gt; Approved for Enlarged Prostate&lt;/a&gt;&lt;font size="-1" color="#6f6f6f"&gt;&lt;nobr&gt;BusinessWeek&lt;/nobr&gt;&lt;/font&gt;&lt;/font&gt;&lt;br&gt;&lt;font size="-1" class="p"&gt;&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fmen.webmd.com%2Fprostate-enlargement-bph%2Fnews%2F20100302%2Fgeneric-drug-enlarged-prostate&amp;amp;usg=AFQjCNH_LksB-s35CyloFsCwAtGaZKzYUA"&gt;&lt;nobr&gt;WebMD&lt;/nobr&gt;&lt;/a&gt;&amp;nbsp;-&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.livemint.com%2F2010%2F03%2F04221124%2FRanbaxy-may-still-gain-from-Fl.html&amp;amp;usg=AFQjCNGeYGdGlFU3dnoG9f_3fgPhB1yLUA"&gt;&lt;nobr&gt;Livemint&lt;/nobr&gt;&lt;/a&gt;&amp;nbsp;-&lt;a target="_blank" rel="nofollow" href="http://news.google.com/news/url?fd=R&amp;amp;sa=T&amp;amp;url=http%3A%2F%2Fwww.fiercepharma.com%2Fstory%2Franbaxy-flubs-launch-generic-flomax%2F2010-03-03&amp;amp;usg=AFQjCNFsIfEUgxmm29c2rV-17sAW9CHU6g"&gt;&lt;nobr&gt;FiercePharma&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;br&gt;&lt;font class="p" size="-1"&gt;&lt;a target="_blank" rel="nofollow" class="p" href="http://news.google.com/news/more?ned=us&amp;amp;ncl=dJLDaH4w3Fn5kZM5Bs4gOJYmtOkkM"&gt;&lt;nobr&gt;&lt;b&gt;all 151 news articles&amp;nbsp;&amp;raquo;&lt;/b&gt;&lt;/nobr&gt;&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-7343259379837706431?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/03/indian-stock-market-and-companies-daily.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-1183934244906435057</guid><pubDate>Sat, 20 Mar 2010 12:08:00 +0000</pubDate><atom:updated>2010-03-20T12:08:15.565Z</atom:updated><title>Fungicide and Insecticide Safe For Human Consumption - PRLog (free press release)</title><description>&lt;a target="_blank" rel="nofollow" href="http://www.prlog.org/10584580-fungicide-and-insecticide-safe-for-human-consumption.html" &gt;Fungicide and Insecticide Safe For Human Consumption - PRLog (free press release)&lt;/a&gt;&lt;br&gt;With the growing demand for healthy and organic foods, many consumers are looking for healthier choices when it comes to household products. Neem Oil fits that bill. Neem is a  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.mycentraljersey.com/article/20100319/GETPUBLISHED/3190321/-1/newsfront/Windsor-Dermatology-s-Dr.-Jerry-Bagel-Receives-Top-Honors" &gt;Windsor Dermatology's Dr. Jerry Bagel Receives Top   - MyCentralJersey.com&lt;/a&gt;&lt;br&gt;Dr. Jerry Bagel, a nationally recognized expert in the treatment of psoriasis with experience treating Central New Jersey patients for 25 years, has received the top referrer award  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.earthtimes.org/articles/show/hemp-cosmetics-from-the,1213611.shtml" &gt;Hemp cosmetics from the Czech Republic helps psoriasis   - Earthtimes&lt;/a&gt;&lt;br&gt;(1888PressRelease) - Skin problems, their origin and treatment hemp cosmetics. Do you suffer from psoriasis or eczema and even using the ointment and creams presribed by the doctor  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.moneycontrol.com/news/business/piramal-life/s-tinefcon-passes-american-derma-jury-test_447437.html" &gt;Piramal Life's Tinefcon passes American derma jury test - MoneyControl.com&lt;/a&gt;&lt;br&gt;Piramal Life Sciences , a part of the Piramal Group of companies, has introduced Tinefcon, a newly-developed natural remedy for Psoriasis (a chronic, non-infectious disease that  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.24-7pressrelease.com/press-release/helpful-holistic-skin-care-tip-for-a-glowing-complexion-rev-up-your-digestion-142495.php" &gt;Helpful Holistic Skin Care Tip: For A Glowing   - 24-7PressRelease.com&lt;/a&gt;&lt;br&gt;Nikkel Holistic Skincare founder Dana McCants shares tips on how to improve skin through better digestion. March 18, 2010 /EIN News/ -- Nikkel Holistic Skincare founder Dana  &lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-1183934244906435057?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/03/fungicide-and-insecticide-safe-for.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-3271048168919280014</guid><pubDate>Mon, 15 Mar 2010 04:08:00 +0000</pubDate><atom:updated>2010-03-15T04:08:43.269Z</atom:updated><title>Physicians' Health Study</title><description>&lt;b&gt;Conditions&lt;/b&gt;:    Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia&lt;br&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: aspirin;   Drug: carotene&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Heart, Lung, and Blood Institute (NHLBI)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified May 2005        &lt;a target="_blank" rel="nofollow" href='http://clinicaltrials.gov/ct2/show/NCT00000500       '&gt;go on..&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    Osteoporosis&lt;br&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Human parathyroid hormone [hPTH-(1-34)];   Drug: alendronate&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified November 2008        &lt;a target="_blank" rel="nofollow" href='http://clinicaltrials.gov/ct2/show/NCT00000400       '&gt;go on..&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    HIV Infections&lt;br&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Abacavir sulfate&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Glaxo Wellcome&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified December 1998        &lt;a target="_blank" rel="nofollow" href='http://clinicaltrials.gov/ct2/show/NCT00002200       '&gt;go on..&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    Opioid-Related Disorders&lt;br&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: LAAM&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute on Drug Abuse (NIDA)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified March 1995        &lt;a target="_blank" rel="nofollow" href='http://clinicaltrials.gov/ct2/show/NCT00000300       '&gt;go on..&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    HIV Infections&lt;br&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Ampligen&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified August 1991        &lt;a target="_blank" rel="nofollow" href='http://clinicaltrials.gov/ct2/show/NCT00001000       '&gt;go on..&lt;/a&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-3271048168919280014?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/03/physicians-health-study.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-5966610341006848647</guid><pubDate>Thu, 11 Mar 2010 23:09:00 +0000</pubDate><atom:updated>2010-03-11T23:09:25.048Z</atom:updated><title>ASCO GU: Prostate CA Prevention Affirmed for BPH Drug - MedPage Today</title><description>&lt;a target="_blank" rel="nofollow" href="http://www.medpagetoday.com/MeetingCoverage/ASCOGU/18855" &gt;ASCO GU: Prostate CA Prevention Affirmed for BPH Drug - MedPage Today&lt;/a&gt;&lt;br&gt;Explain to interested patients that several trials have now affirmed a benefit of the BPH drugs in the 5-alpha reductase class in preventing incidence of prostate cancer, which the  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.investors.com/NewsAndAnalysis/Article.aspx?id=525815" &gt;U.S. Stocks Etch New Session Highs - Investors Business Daily&lt;/a&gt;&lt;br&gt;Volume was tracking higher across the board. Meanwhile, the Dow and NYSE composite rose 0.2% each while the NYSE composite edged up a fraction. UAL Corp. ( UAUA ) jumped 8% to a  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.thesunnews.com/2010/03/08/1357694/acura-king-cite-positive-study.html" &gt;Acura, King cite positive study on pain drug - The Sun News&lt;/a&gt;&lt;br&gt;NEW YORK -- Acura Pharmaceuticals Inc. and King Pharmaceuticals Inc. said Monday the potential abuse-resistant painkiller Acurox met key goals in a pivotal study. The companies  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.wsfa.com/Global/story.asp?S=12075313" &gt;Generic Flomax approved for enlarged prostate - WSFA&lt;/a&gt;&lt;br&gt;TUESDAY, March 2 (HealthDay News) -- The first generic version of Flomax (tamsulosin hydrochloride) capsules has been approved by the U.S. Food and Drug Administration to treat  &lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-5966610341006848647?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/03/asco-gu-prostate-ca-prevention-affirmed.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-9143537714887077630</guid><pubDate>Wed, 10 Mar 2010 23:08:00 +0000</pubDate><atom:updated>2010-03-10T23:08:33.173Z</atom:updated><title>Medivation, Pfizer Disappointed Over Drug Failure - Biotech's Latest - Seekingalpha.com</title><description>&lt;a target="_blank" rel="nofollow" href="http://seekingalpha.com/article/192315-medivation-pfizer-disappointed-over-drug-failure-biotech-s-latest-mishaps" &gt;Medivation, Pfizer Disappointed Over Drug Failure - Biotech's Latest   - Seekingalpha.com&lt;/a&gt;&lt;br&gt;Pfizer ( PFE ) and Medivation ( MDVN ) said dimebon, their experimental drug to treat Alzheimer’s disease, failed in two late-stage clinical trials. Medivation’s stock, which  &lt;br&gt;&lt;br&gt;&lt;a target="_blank" rel="nofollow" href="http://www.investors.com/NewsAndAnalysis/Article.aspx?id=525815" &gt;U.S. Stocks Etch New Session Highs - Investors Business Daily&lt;/a&gt;&lt;br&gt;Volume was tracking higher across the board. Meanwhile, the Dow and NYSE composite rose 0.2% each while the NYSE composite edged up a fraction. UAL Corp. ( UAUA ) jumped 8% to a  &lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-9143537714887077630?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/03/medivation-pfizer-disappointed-over.html</link><author>noreply@blogger.com (MarcoPolo)</author></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4834655537110960213.post-5868405710051139387</guid><pubDate>Sun, 07 Mar 2010 19:08:00 +0000</pubDate><atom:updated>2010-03-07T19:08:47.463Z</atom:updated><title>A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP</title><description>&lt;i&gt;&lt;b&gt;A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP       &lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;b&gt;Condition&lt;/b&gt;:    HIV Infections&lt;br&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Zidovudine&lt;br&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br&gt;&lt;b&gt;Completed&lt;/b&gt; - verified September 2002       &lt;br&gt;&lt;i&gt;Source: clinicaltrials.gov&lt;/i&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4834655537110960213-5868405710051139387?l=go-discover.com%2FFlomax_Psoriasis' alt='' /&gt;&lt;/div&gt;</description><link>http://go-discover.com/Flomax_Psoriasis/2010/03/multi-center-clinical-trial-to-evaluate.html</link><author>noreply@blogger.com (MarcoPolo)</author></item></channel></rss>